USANA: Omni-Channel Ambition Meets the Hard Reality of a Guidance Cut
A $29M goodwill impairment and softer venture-brand outlook cloud the diversification story, but the core remains stable.
USNA · Earnings Call · 2026-08-05
A Quarter of Recalibration
USANA's second-quarter report was a study in contrasts. Management framed the quarter as progress toward a omni channel health future, yet the numbers reveal a company in a delicate transition. The most glaring item was a $29 million non-cash goodwill impairment tied to the Hiya reporting unit, which CFO Doug Hekking attributed to "“lower than expected performance and changes in near-term forecasts” — Doug Hekking, Chief Financial Officer · 2026-08-05" as well as updated valuation assumptions. Combined with a $9 million income tax expense on a pre-tax loss of $19 million, the quarter pushed USANA into a net loss. More importantly, the company cut its full-year outlook, explicitly citing the difficult direct-to-consumer digital marketing environment for Hiya and a packaging issue at Rise Wellness. CEO Kevin Guest tried to reassure investors that the path is right, saying, "We're building something different, evolving the company" — but the market's reaction has been unforgiving: the stock is down 39% over the last three weeks, and the 90-day trend shows a peak-to-trough drawdown of 41.7%. The company's venture brands are the source of both excitement and current pain.The Venture Brands: Hiya and Rise Hit Speed Bumps
Hiya, the children's health brand acquired two years ago, is the biggest drag. Walter Noot, COO, admitted on the call: "“We've had issues with Meta's algorithm and it's created issues for us as far as customer acquisition.” — Walter Noot, Chief Operating Officer · 2026-08-05" This is not a new problem — it was flagged as far back as the October 2025 call, where Noot said, "“Meta has changed algorithms and so we're trying to figure that out.” — Walter Noot · 2025-10-23" The persistence of this issue underscores a structural challenge: USANA's once-rapid DTC growth engine is now fighting for customers in a more expensive digital world. Management is pushing into TikTok and retail (Target, Canada, U.K.) to diversify, but the near-term top line is suffering. Rise Wellness, the protein snack brand, had a "cosmetic issue with some packaging" that forced a temporary halt in the quarter. While Noot emphasized it was not a safety issue, the disruption caused a sizable revenue impact and contributed to the guidance revision. The wellness company narrative remains intact, but the execution is uneven.The Core Holds, and GLOW Signals a New Direction
Beneath the noise, the core nutritional business is showing resilience. Mainland China, the largest market, returned to growth in Q2, driven by a strong first-quarter incentive launch that carried over. Brent Neidig, Chief Commercial Officer, noted "“the tail from that robust incentive and new product launch continued in the second quarter.” — Brent Neidig, Chief Commercial Officer · 2026-08-05" Management's confidence is echoed in the launch of GLOW, a skin-health supplement, which Kevin Guest called a test of the company's ability to reach new consumers. Catherine Armstrong highlighted the clinical data behind the product, emphasizing that USANA starts "with ingredients that have strong clinical data" and validates them through consumer challenge tests. This is the essence of the omni channel health strategy: leveraging science across channels and demographics. But the financial picture remains muted. Total revenue is flat year-over-year at $250M, and net income has collapsed from a $44M peak in Q2 2021 to just $8M this quarter. Margins tell the same story: gross margin has slipped from 83% to 76%, and operating margin sits at 6.2%. The balance sheet, however, is a bright spot — $169M in cash and zero debt — giving management dry powder to weather the storm.That vision is compelling, but the market is pricing in a more skeptical outlook. At a price-to-revenue multiple of 0.3x, investors are treating USANA as a declining asset rather than a growth story. The recent 90-day price action — a drop of over 25% — suggests the street sees the guidance cut as a canary in the coal mine.We're building a diversified, omni-channel health and wellness company anchored by science and built on deep, lasting consumer loyalty.